Skip to main content
logo
Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
5.29
+0.16 (3.02%)
May 27, 2026, 4:00 PM EDT - Market closed

Bolt Biotherapeutics Revenue

Bolt Biotherapeutics had revenue of $26.00K in the quarter ending March 31, 2026, a decrease of -97.87%. This brings the company's revenue in the last twelve months to $6.50M, up 78.64% year-over-year. In the year 2025, Bolt Biotherapeutics had annual revenue of $7.70M with 0.07% growth.

Revenue (ttm)
$6.50M
Revenue Growth
+78.64%
P/S Ratio
1.52
Revenue / Employee
$282,565
Employees
23
Market Cap
10.16M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20257.70M5.00K0.07%
Dec 31, 20247.69M-186.00K-2.36%
Dec 31, 20237.88M2.15M37.48%
Dec 31, 20225.73M4.47M354.68%
Dec 31, 20211.26M1.03M445.45%
Dec 31, 2020231.00K16.00K7.44%
Dec 31, 2019215.00K--
Dec 31, 2018---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

BOLT News

More News